Alshahrani Saad, Binsaleh Abdulrahman, Alghamdi Ahmed Othman, Alqasem Saad, Al-Gonaim Ali, El-Metwally Ashraf
Department of Surgery, Division of Urology, College of Medicine, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.
J Clin Med. 2025 Jun 19;14(12):4367. doi: 10.3390/jcm14124367.
: This study aimed to evaluate perceptions and practices of urologists in Saudi Arabia regarding discussions of erectile dysfunction (ED) and ejaculatory dysfunction (EjD) with patients before initiating BPH treatments. : A cross-sectional survey was conducted using a structured questionnaire distributed during the 36th Saudi Urological Annual Conference held in Riyadh in February 2025 among urologists in Saudi Arabia. A binary outcome variable, "frequent and open discussion," was created based on a scoring system using the median score of these responses. Data analysis included descriptive statistics and univariate ( < 0.25) and multivariate ( < 0.05) logistic regression using SPSS version 27. : Discussions about ED risks were most frequent before prescribing 5-alpha reductase inhibitors (5-ARIs) (51.3%) and combined alpha-blockers and 5-ARIs therapy (50.0%), whereas EjD risks were more frequently addressed before alpha-blocker monotherapy (59.2%) and transurethral resection of the prostate (TURP) (56.6%). A substantial proportion of urologists discussed alternative treatments based on sexual dysfunction risks, particularly before TURP (53.9%), alpha-blockers (47.4%), and 5-ARIs (43.4%). Univariate analysis revealed a trend towards more open discussions among non-Saudi urologists (OR 4.58, 95% CI 0.88-23.74, = 0.06) and a significant association with working in private hospitals (OR 3.68, 95% CI 0.39-35.14, = 0.03). However, these associations did not hold in multivariate analysis. : Urologists in Saudi Arabia demonstrate variability in discussing sexual complications with patients before BPH treatments. Consistent and comprehensive discussions about ED and EjD risks are crucial for informed patient decision-making. Standardized guidelines and educational programs are needed to enhance urologists' communication skills and ensure consistent patient counseling.
本研究旨在评估沙特阿拉伯泌尿外科医生在启动良性前列腺增生（BPH）治疗前与患者讨论勃起功能障碍（ED）和射精功能障碍（EjD）的认知和实践情况。
在2025年2月于利雅得举行的第36届沙特泌尿外科年会上，向沙特阿拉伯的泌尿外科医生发放结构化问卷，进行了一项横断面调查。基于这些回答的中位数得分，使用评分系统创建了一个二元结果变量“频繁且开放的讨论”。数据分析包括描述性统计以及使用SPSS 27版本进行的单变量（<0.25）和多变量（<0.05）逻辑回归。
在开具5α还原酶抑制剂（5-ARIs）（51.3%）以及联合使用α受体阻滞剂和5-ARIs治疗（50.0%）之前，关于ED风险的讨论最为频繁；而在α受体阻滞剂单药治疗（59.2%）和经尿道前列腺切除术（TURP）（56.6%）之前，EjD风险的讨论更为频繁。相当一部分泌尿外科医生会根据性功能障碍风险讨论替代治疗方法，尤其是在TURP（53.9%）、α受体阻滞剂（47.4%）和5-ARIs（43.4%）治疗之前。单变量分析显示，非沙特泌尿外科医生有进行更开放讨论的趋势（比值比4.58，95%置信区间0.88 - 23.74，P = 0.06），且与在私立医院工作有显著关联（比值比3.68，95%置信区间0.39 - 35.14，P = 0.03）。然而，这些关联在多变量分析中并不成立。
沙特阿拉伯的泌尿外科医生在BPH治疗前与患者讨论性并发症方面表现出差异。关于ED和EjD风险进行一致且全面的讨论对于患者做出明智决策至关重要。需要标准化指南和教育项目来提高泌尿外科医生的沟通技巧，并确保为患者提供一致的咨询服务。
